Tumor response assessment in hepatocellular carcinoma treated with immunotherapy: imaging biomarkers for clinical decision-making.

Rabea SobireyNickolai MatuschewskiMoritz GrossMingDe LinTabea KaoVictor KasolowskyMario StrazzaboscoStacey SteinLynn Jeanette SavicBernhard GebauerAriel JaffeJames DuncanDavid C MadoffJulius Chapiro

Published in: European radiology (2024)

MRI-based tumor response criteria predict immunotherapy survival benefits in HCC patients. 3D tumor response assessment methods surpass current evaluation criteria in predicting overall survival during HCC immunotherapy. Enhancement-based 3D tumor response criteria are robust prognosticators of survival for HCC patients on immunotherapy.

Keyphrases

end stage renal disease
newly diagnosed
chronic kidney disease
ejection fraction
decision making
prognostic factors
magnetic resonance imaging
computed tomography
free survival
patient reported outcomes